Skip to content

Clinical trials

Thrombotic Microangiopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombotic Microangiopathies Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20143
20151
20172
20184
20191
20203
20218
20222
20236
202410
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed12
Unknown status8
Withdrawn5
Terminated5
Not yet recruiting3
Active, not recruiting1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.6
Novartis Pharmaceuticals3
Omeros Corporation3
The First Affiliated Hospital of Soochow University3
Assistance Publique - Hôpitaux de Paris2
Children's Hospital Medical Center, Cincinnati2
University Hospital, Rouen2
University Hospital, Tours2
University of California, San Francisco2
AKARI Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombotic Microangiopathies49
Atypical Hemolytic Uremic Syndrome13
Purpura, Thrombotic Thrombocytopenic7
Hemolytic-Uremic Syndrome6
Thrombocytopenia5
Acute Kidney Injury3
Hematologic Diseases3
Kidney Diseases3
Purpura, Thrombocytopenic, Idiopathic3
Anemia, Hemolytic2

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.